Table of contents
March 2005 Vol 5 No 3
In this issue
p151 | doi:10.1038/nrc1585
Research Highlights
Tumour suppressors: House of cards
p153 | doi:10.1038/nrc1581
In the news
Second-hand smoke
p154 | doi:10.1038/nrc1579
Epigenetics: A silenced suppressor
p154 | doi:10.1038/nrc1580
Inflammation: Inflammation: Well connected
p154 | doi:10.1038/nrc1582
In brief
Therapeutics | Viral oncogenesis | Tumour progression | Genetics
p155 | doi:10.1038/nrc1578
Tumorigenesis: Growing through GEFs
p156 | doi:10.1038/nrc1574
Oesophageal cancer: Smoke and mirrors
p156 | doi:10.1038/nrc1575
Leukaemia: Space shuttle
p157 | doi:10.1038/nrc1572
Metabolism: Clash of therapies?
p158 | doi:10.1038/nrc1573
Therapeutics: Susceptibility or resistance?
p158 | doi:10.1038/nrc1577
Pharmacology: Transporter for milk toxins
p159 | doi:10.1038/nrc1576
Trial Watch
Auroras in the limelight | Zapping follicular lymphoma
p159 | doi:10.1038/nrc1583
Reviews
View Correspondence (July 2005) and related Reply (July 2005) associated with this article.
Cancer nanotechnology: opportunities and challenges
Mauro Ferrari
p161 | doi:10.1038/nrc1566
Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia
Ruibao Ren
p172 | doi:10.1038/nrc1567
The promise of genetically engineered mice for cancer prevention studies
Jeffrey E. Green & Tamaro Hudson
p184 | doi:10.1038/nrc1565
Colorectal cancer screening: prospects for molecular stool analysis
R. Justin Davies, Richard Miller & Nicholas Coleman
p199 | doi:10.1038/nrc1569
Testicular germ-cell tumours in a broader perspective
J. Wolter Oosterhuis & Leendert H. J. Looijenga
p210 | doi:10.1038/nrc1568
Perspectives
Innovation
Detection and interpretation of altered methylation patterns in cancer cells
Toshikazu Ushijima
p223 | doi:10.1038/nrc1571
Opinion
The role of apoptosis in cancer development and treatment response
J. Martin Brown & Laura D. Attardi
p231 | doi:10.1038/nrc1560
